Perennial Advisors’s Gilead Sciences GILD Stock Holding History

Perennial Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-948	Closed	-$65K	–	148
2021 Q2	$65K	Sell	948 -75	-7%	-$5.01K	0.02%	137
2021 Q1	$66K	Buy	1,023 +223	+28%	+$14.4K	0.02%	133
2020 Q4	$47K	Buy	+800	New	+$48.3K	0.02%	144
2020 Q3	–	Sell	-857	Closed	-$66K	–	127
2020 Q2	$66K	Buy	+857	New	+$65.7K	0.03%	112
2019 Q1	–	Sell	-700	Closed	-$44K	–	121
2018 Q4	$44K	Sell	700 -200	-22%	-$14K	0.03%	105
2018 Q3	$69K	Sell	900 -200	-18%	-$15.1K	0.04%	95
2018 Q2	$78K	Hold	1,100	–	–	0.05%	93
2018 Q1	$83K	Sell	1,100 -200	-15%	-$15.9K	0.05%	89
2017 Q4	$93K	Hold	1,300	–	–	0.06%	92
2017 Q3	$105K	Sell	1,300 -400	-24%	-$30.6K	0.07%	86
2017 Q2	$120K	Sell	1,700 -18	-1%	-$1.2K	0.09%	81
2017 Q1	$117K	Sell	1,718 -375	-18%	-$26.4K	0.09%	81
2016 Q4	$150K	Buy	+2,093	New	+$156K	0.12%	77

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perennial Advisors's GILD Position: Q3 2021 in Review

Perennial Advisors sold out of Gilead Sciences (GILD) in Q3 2021, closing a stake of 948 shares — an estimated $65K sold.

Perennial Advisors first reported a position in GILD in Q4 2016 and held it in 13 quarters. The position peaked at $150K in Q4 2016. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Perennial Advisors reported no remaining Gilead Sciences position as of Q3 2021 after selling out during the quarter.
Perennial Advisors sold 948 Gilead Sciences shares in Q3 2021, an estimated $65K.
Perennial Advisors first reported a position in Gilead Sciences in Q4 2016 and held it in 13 quarters.
Perennial Advisors's Gilead Sciences position peaked at $150K in Q4 2016.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Perennial Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.